CD4 and type 1 diabetes mellitus: NOD.MDA5+/− exhibit a delay in spontaneous and CVB-induced T1D, have reduced CD4 and CD8 T cell effector responses, and have enhanced Treg functionality compared to WT NOD mice [242].